Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Cash from Financing Activities (2018 - 2025)

TELA Bio (TELA) has 8 years of Cash from Financing Activities data on record, last reported at $24000.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 75.51% year-over-year to $24000.0; the TTM value through Sep 2025 reached $42.8 million, up 24936.84%, while the annual FY2024 figure was $43.1 million, 6.94% down from the prior year.
  • Cash from Financing Activities reached $24000.0 in Q3 2025 per TELA's latest filing, up from -$3000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $46.4 million in Q2 2023 and bottomed at -$235000.0 in Q1 2023.
  • Average Cash from Financing Activities over 5 years is $6.9 million, with a median of $56000.0 recorded in 2024.
  • Peak YoY movement for Cash from Financing Activities: crashed 505.56% in 2022, then surged 194936.36% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $174000.0 in 2021, then tumbled by 225.86% to -$219000.0 in 2022, then surged by 110.05% to $22000.0 in 2023, then soared by 194936.36% to $42.9 million in 2024, then crashed by 99.94% to $24000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $24000.0 in Q3 2025, -$3000.0 in Q2 2025, and -$116000.0 in Q1 2025.